Paul Steven M insider trades
Paul Steven M has filed 20 Form 4s with the SEC that we hold, for KRTX (Director), SAGE (Director), Rapport Therapeutics, Inc. (RAPP) (Director) and Alnylam Pharmaceuticals, INC. (ALNY) (Director), among 5 companies in all. Across all of them we count 4 purchases worth $1.3M and 10 sales worth $2.6M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 4,948 shares of Alnylam Pharmaceuticals, INC. worth $836.0K, dated 2022-04-01. The first filing on our record is dated 2021-07-19 and the latest 2026-06-10.
KRTX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-17 | P, purchase reported on Form 4 | 1,183 | $125.0K | 2021-08-18 |
| 2021-08-18 | P, purchase reported on Form 4 | 1,181 | $125.3K | 2021-08-18 |
SAGE
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Rapport Therapeutics, Inc. (RAPP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-09-12 | P, purchase reported on Form 4 | 28,284 | $693.0K | 2025-09-15 |
| 2025-09-12 | P, purchase reported on Form 4 | 13,382 | $334.1K | 2025-09-15 |
Alnylam Pharmaceuticals, INC. (ALNY)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-04-01 | S, sale reported on Form 4 | 175 | $31.3K | 2022-04-05 |
| 2022-04-01 | S, sale reported on Form 4 | 825 | $146.5K | 2022-04-05 |
| 2022-04-01 | S, sale reported on Form 4 | 526 | $92.8K | 2022-04-05 |
| 2022-04-01 | S, sale reported on Form 4 | 90 | $15.7K | 2022-04-05 |
| 2022-04-01 | S, sale reported on Form 4 | 642 | $111.1K | 2022-04-05 |
| 2022-04-01 | S, sale reported on Form 4 | 253 | $42.0K | 2022-04-05 |
| 2022-04-01 | S, sale reported on Form 4 | 4,948 | $836.0K | 2022-04-05 |
| 2022-04-01 | S, sale reported on Form 4 | 4,872 | $826.8K | 2022-04-05 |
| 2022-04-01 | S, sale reported on Form 4 | 1,235 | $211.4K | 2022-04-05 |
| 2022-04-01 | S, sale reported on Form 4 | 1,434 | $246.8K | 2022-04-05 |
Seaport Therapeutics, Inc. (SPTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1237564) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms